# LLM call: summary

- Turn: 4
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 792
- Completion tokens: 244
- Total tokens: 1036
- Cost (USD): 0.000128

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1148: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn brought two shocks: confirmation that genome models helped shape a modified pathogen causing casualties in a non-European port city forced HERA/allied sequencing and countermeasure surge; EU saw only imported scares but moved bio-detection from paper to field deployment.

Interpretability research yielded a certified control technique adopted as EU evaluation procurement standard to press foreign providers for retrofits for market access — partial compliance but first testable demand.

Washington ordered deeper lithography export/servicing cuts including older machines, pressuring extension to others via US tech leverage on Netherlands/ASML. Brussels opened anti-coercion examination and sought Japan/South Korea alignment for volume licences and power-price relief; gigafactory talks in Paris, Berlin, Madrid, Stockholm, Warsaw yielded permitting zones but no funds or construction. Spare stockpiling bought time, not independence.

Grid operators shared prior intrusion indicators and tightened monitoring, but OT retrofits still years away. By December: better monitored and stocked, but more openly dependent.

CURRENT NARRATIVE:
### Cut off
In March, hospitals in three member states, a handful of ministries and a cluster of suppliers found their calls to the leading foreign model failing. No reason, no timetable, no appeal — only a status notice and a helpline that did not answer. Clinicians who had built triage summaries and procurement teams who had built tender screening on top of it reverted to phones and paper for a week. Opposition press called it a failure of foresight; government press called it blackmail.

Brussels answered with what it could sign quickly. Health and interior ministers mandated HERA, the disease agency and the cyber agency to join a pooled pact already forming among states hit by the same bio and intrusion wave: binding sample-sharing, real-time telemetry feeds, seconded analysts. At home, emergency funds were shifted to fallback inference for affected public services and to turning the fielded bio-detectors into standing surveillance.

### The open flood
Almost at the same moment, a new openly released model landed within months of the closed frontier. Hundreds of thousands of downloads in the first week put near-frontier capability on private hardware permanently. University labs celebrated; security services did not. Vetted versions were hastily offered to hospitals as a substitute, but administrators complained they behaved differently and needed guardrails no one had written.

The evaluation institute set up last year finally opened its doors and published its first test demands, while the hardening programme declared its hospital and grid pilots operational. Both helped absorb the shock — detection was faster, recovery less chaotic — but neither restored the lost access.

Gigafactory zones stayed empty fields with permits and power-price promises but no concrete. The anti-coercion examination ground on, with Tokyo and Seoul listening but not committing, and Washington unmoved. By June, Europe was better connected to its partners and better monitored at home — and running its essential services on borrowed and substitute intelligence.
```

## Raw response

```
Autumn shocks over a model-shaped pathogen drove HERA/allied sequencing surge and EU fielding of bio-detectors; interpretability control technique became EU procurement standard to pressure foreign retrofits; US lithography cuts triggered EU anti-coercion probe and gigafactory permitting zones without funds.

In March, leading foreign model access was cut off for hospitals, ministries and suppliers in three member states, forcing week-long reversion to manual work and seen as coercion. Brussels responded with binding HERA-disease-cyber pact on sample-sharing, telemetry and seconded analysts, plus emergency funds for fallback inference and standing bio-surveillance.

Simultaneously an open near-frontier model spread to private hardware, celebrated by labs but straining security and hospital substitution. Evaluation institute issued first test demands; hardening pilots for hospitals/grids became operational, improving detection/recovery but not restoring access. Gigafactory sites remained unbuilt; Japan/South Korea uncommitted, Washington unmoved. By June: better allied-connected and monitored, but dependent on borrowed/substitute AI.
```
